Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Neurobiol Aging. 2019 Jan 21;77:26–36. doi: 10.1016/j.neurobiolaging.2019.01.008

Table 2:

Pathology distribution

All (n=161) Subjects with imaging (n=102)
β-Amyloid Stage
  0 69 (43%) 44 (43%)
  1 50 (31%) 30 (29%)
  2 29 (18%) 19 (19%)
  3 13 (8%) 9 (9%)
Tau Stage
  0 4 (3%) 1 (1%)
  1 20 (12%) 11 (11%)
  2 53 (33%) 36 (35%)
  3 41 (26%) 27 (27%)
  4 25 (16%) 14 (14%)
  5 16 (10%) 11 (11%)
  6 2 (1%) 2 (2%)
α-Synuclein Stage
  0 139 (87%) 88 (87%)
  1 9 (6%) 7 (7%)
  2 8 (5%) 4 (4%)
  3 4 (3%) 2 (2%)
TDP-43 Stage
  0 126 (81%) 76 (75%)
  1 14 (9%) 13 (13%)
  2 6 (4%) 4 (4%)
  3 2 (1%) 2 (2%)
  4 0 (0%) 0 (0%)
  5 7 (5%) 7 (7%)
  6 0 (0%) 0 (0%)
Vascular Stage
  0 83 (52%) 49 (49%)
  1 20 (13%) 16 (16%)
  2 42 (26%) 26 (26%)
  3 15 (9%) 10 (10%)